Send mail to Author

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 ______    __   __   __   __   _    _    _    _      ___    
|      \\  \ \\/ //  \ \\/ // | || | || | |  | ||   / _ \\  
|  --  //   \ ` //    \   //  | || | || | |/\| ||  / //\ \\ 
|  --  \\    | ||     / . \\  | \\_/ || |  /\  || |  ___  ||
|______//    |_||    /_//\_\\  \____//  |_// \_|| |_||  |_||
`------`     `-`'    `-`  --`   `---`   `-`   `-` `-`   `-`
 


Back to frontdoor view

OPUS4 Logo